Option Care Health (NASDAQ:OPCH) Price Target Raised to $40.00

Option Care Health (NASDAQ:OPCH) had its price target lifted by equities research analysts at JPMorgan Chase & Co. from $38.00 to $40.00 in a research note issued on Friday,Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price points to a potential upside of 32.31% from the stock’s current price.

A number of other research firms have also weighed in on OPCH. JMP Securities reissued a “market outperform” rating and issued a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and increased their price objective for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Truist Financial decreased their target price on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Barrington Research boosted their price objective on shares of Option Care Health from $32.00 to $33.00 and gave the company an “outperform” rating in a research report on Tuesday, January 14th. Finally, The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $38.00 to $27.00 in a report on Monday, November 4th. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $32.25.

Option Care Health Price Performance

Shares of NASDAQ OPCH traded up $0.23 during mid-day trading on Friday, reaching $30.23. 193,109 shares of the company were exchanged, compared to its average volume of 2,206,669. Option Care Health has a 52 week low of $21.39 and a 52 week high of $34.63. The company’s 50 day moving average price is $24.26 and its 200 day moving average price is $27.80. The stock has a market capitalization of $5.14 billion, a PE ratio of 25.40, a PEG ratio of 2.11 and a beta of 1.31. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the firm’s stock in a transaction on Friday, November 8th. The stock was acquired at an average price of $22.54 per share, with a total value of $969,220.00. Following the completion of the purchase, the director now owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.64% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in OPCH. Wellington Management Group LLP boosted its holdings in Option Care Health by 15.5% in the third quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company’s stock worth $310,650,000 after acquiring an additional 1,328,326 shares in the last quarter. FMR LLC boosted its stake in Option Care Health by 134.0% in the 3rd quarter. FMR LLC now owns 7,516,448 shares of the company’s stock worth $235,265,000 after purchasing an additional 4,304,896 shares in the last quarter. Westfield Capital Management Co. LP grew its position in Option Care Health by 10.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock valued at $203,204,000 after purchasing an additional 599,589 shares during the last quarter. State Street Corp increased its stake in Option Care Health by 1.4% during the 3rd quarter. State Street Corp now owns 6,257,172 shares of the company’s stock valued at $195,849,000 after purchasing an additional 83,395 shares in the last quarter. Finally, Thrivent Financial for Lutherans raised its holdings in Option Care Health by 7.4% in the third quarter. Thrivent Financial for Lutherans now owns 5,863,930 shares of the company’s stock worth $183,541,000 after buying an additional 404,811 shares during the last quarter. Institutional investors own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.